How do I buy Enlivex Therapeutics (ENLV) stock?

You can purchase shares of Enlivex Therapeutics (NASDAQ:ENLV) through any online brokerage.View our list of the best stock brokerages

Who are Enlivex Therapeutics (ENLV) competitors?

Other companies in Enlivex Therapeutics’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Humacyte Inc (NASDAQ:HUMA), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL), Voyager Therapeutics Inc (NASDAQ:VYGR) and Larimar Therapeutics Inc (NASDAQ:LRMR).

What is the forecast, or price target, for Enlivex Therapeutics (ENLV) stock?

Enlivex Therapeutics has a consensus price target of $13.00.

What is the current price for Enlivex Therapeutics (ENLV)?

The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $0.9888 last updated January 15, 2026 at 10:43 AM EST.

Does Enlivex Therapeutics (ENLV) pay a dividend?

There are no upcoming dividends for Enlivex Therapeutics.

When is Enlivex Therapeutics (NASDAQ:ENLV) reporting earnings?

Enlivex Therapeutics does not have any upcoming earnings scheduled.

Is Enlivex Therapeutics (ENLV) going to split?

There is no upcoming split for Enlivex Therapeutics.

What sector and industry does Enlivex Therapeutics (ENLV) operate in?

Enlivex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Enlivex Therapeutics (ENLV) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy t...

Comments